عرض سجِل بسيط للمادة

dc.contributor.authorWorld Health Organizationen_US
dc.coverage.spatialGenevaen_US
dc.date.accessioned2019-07-08T09:52:55Z
dc.date.available2019-07-08T09:52:55Z
dc.date.issued2019
dc.identifier.govdocWHO/MVP/EMP/IAU/2019.05
dc.identifier.urihttps://iris.who.int/handle/10665/325773
dc.description27 p.en_US
dc.language.isoenen_US
dc.publisherWorld Health Organizationen_US
dc.rightsCC BY-NC-SA 3.0 IGOen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0/igoen_US
dc.subject.meshDrugs, Essentialen_US
dc.subject.meshGuidelineen_US
dc.subject.meshMeeting Abstracten_US
dc.subject.meshDrug Utilizationen_US
dc.titleExecutive summary: the selection and use of essential medicines 2019: report of the 22nd WHO Expert Committee on the selection and use of essential medicines: WHO Headquarters, Geneva, 1-5 April 2019en_US
dc.typeTechnical documentsen_US
dc.rights.holderWorld Health Organizationen_US


الملفات في هذه المادة

Thumbnail

هذه المادة تظهر في المجموعات التالية

عرض سجِل بسيط للمادة